Aptamers
Group leaders
Víctor Manuel González Muñoz
María Elena Martín Palma
victor.m.gonzalez(ELIMINAR)@hrc.es
Tlf.: +34 91 336 81 73
Collaborating Staff
- María Isabel Pérez Morgado
- Silvia Sacristán López
- María del Val Toledo Lobo
- Marta García Hernández
- Ana María Salgado Figueroa
- Raquel Ferreras Martín
- Ignacio Iturrieta Zuazo
- Manuel Pascual Mellado
- Elena Gala García
Group leaders
Víctor Manuel González Muñoz
María Elena Martín Palma
victor.m.gonzalez(ELIMINAR)@hrc.es
Tlf.: +34 91 336 81 73
Collaborating Staff
- María Isabel Pérez Morgado
- Silvia Sacristán López
- María del Val Toledo Lobo
- Marta García Hernández
- Ana María Salgado Figueroa
- Raquel Ferreras Martín
- Ignacio Iturrieta Zuazo
- Manuel Pascual Mellado
- Elena Gala García
STRATEGIC OBJECTIVES
- Development of detection systems based on aptamer technology aimed at improving the diagnosis and/or prognosis of various pathologies, enabling better patient care and cost savings for the healthcare system.
- Development of aptamers targeting pathways involved in different pathologies (cancer, infections, etc.) for use in drug design, providing new therapeutic options for patients.
- Identification of new therapeutic targets in cancer.
RESEARCH LINES
- Development of aptamers with therapeutic potential.
- Development of aptamer-based diagnostic systems.
- Involvement of the Mnk1b kinase in tumorigenesis.
Location
Ramón y Cajal University Hospital
Aptamer Laboratory
Level -1 Right
Keywords
Aptamer, diagnosis, MNK, therapy